I do have concerns about igf 1 as a competitor, but i do not really understand the science.
The fact so many experts in autism have joined such as Joe Horrigan suggests to me there is a difference and probably a meaningful one as the numerous peolpe who have joined the company do understand the science.
Would these experts have joined if igf 1 was going to win the race? It would have been obvious to them if the answer was yes.
- Forums
- ASX - By Stock
- Wider autism efficacy potential for nnz-2566
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.82%
!
$14.58

I do have concerns about igf 1 as a competitor, but i do not...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.58 |
Change
0.400(2.82%) |
Mkt cap ! $1.815B |
Open | High | Low | Value | Volume |
$14.36 | $14.75 | $14.36 | $3.851M | 264.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 673 | $14.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.60 | 294 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 24 | 14.570 |
6 | 679 | 14.560 |
7 | 1183 | 14.550 |
8 | 1272 | 14.540 |
7 | 1429 | 14.530 |
Price($) | Vol. | No. |
---|---|---|
14.590 | 152 | 5 |
14.600 | 957 | 4 |
14.610 | 800 | 5 |
14.620 | 1240 | 6 |
14.630 | 1240 | 5 |
Last trade - 11.53am 10/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |